Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T14:16:33.039Z.
Calculation as of: 2026-10-06T14:16:33.039Z.
Quote observation: 2026-10-06T14:15:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5811ce025d9976e80ea69b9f8bae613fc78d61205a97c72640e2bc4d521a59ba
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$52.05M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.13M
Price/OCF Ratio
N/A
TTM Avg
13.21
3Y Avg
14.20
5Y Avg
14.20
Market Cap
$54.14M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $52.05M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.31M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $50.28M | 2.06 | 2.08 | 4.49 | 3.97 |
| Microbot Medical Inc. (MBOT)vs › | $50.13M | N/A | 13.21 | 14.20 | 14.20 |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.52M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $49.49M | N/A | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $54.14M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.01M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
